The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
口服核苷前药 GS-5245 对 SARS-CoV-2 以及其他地方性、流行性和地方性冠状病毒有效
期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.adj4504
David R Martinez, Fernando R Moreira, Nicholas J Catanzaro, Meghan V Diefenbacher, Mark R Zweigart, Kendra L Gully, Gabriela De la Cruz, Ariane J Brown, Lily E Adams, Boyd Yount, Thomas J Baric, Michael L Mallory, Helen Conrad, Samantha R May, Stephanie Dong, D Trevor Scobey, Cameron Nguyen, Stephan